Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: A Population-based study of 1149 cases in Taiwan

Journal of Epidemiology

Volumn 23, Issue 1, 2013, Pages 35-40

  Lee, Charles Tzu Chi ^a   Chiu, Yi Wen ^a,b   Wang, Kai Chen ^c   Hwang, Chi Shin ^d   Lin, Kuan Hsiang ^e   Lee, I Ta ^f   Tsai, Ching Piao ^a,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Amyotrophic lateral sclerosis; Riluzole; Survival; Tracheotomy

Indexed keywords

NEUROPROTECTIVE AGENT; RILUZOLE;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; FACTUAL DATABASE; FEMALE; FOLLOW UP; GASTROSTOMY; HUMAN; MALE; MIDDLE AGED; MORTALITY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; SOCIOECONOMICS; SURVIVAL; TAIWAN; TIME; TRACHEOTOMY;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTROSTOMY; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; POSITIVE-PRESSURE RESPIRATION; PROGNOSIS; RETROSPECTIVE STUDIES; RILUZOLE; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TAIWAN; TIME FACTORS; TRACHEOTOMY;

EID: 84874680813     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20120119     Document Type: Article

References (25)

1. Radunovic A, Annane D, Jewitt K, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2009;(4):CD004427.
2. Fong GC, Cheng TS, Lam K, Cheng WK, Mok KY, Cheung CM, et al. An epidemiological study of motor neuron disease in Hong Kong. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(3):164-8.
3. Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol. 2005;15(1): 20-3.
4. Fang F, Valdimarsdóttir U, Bellocco R, Ronnevi LO, Sparén P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66(4):515-9.
5. Borasio GD, Gelinas DF, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol. 1998;245 Suppl 2:S7-12; discussion S29.
6. Heiman-Patterson TD, Miller RG. NIPPV: a treatment for ALS whose time has come. Neurology. 2006;67(5):736-7.
7. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur J Neurol. 2007;14(3):262-8.
8. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis. J Neurosci Nurs. 1996;28(4):275.
9. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994;124 Suppl:96-107.
10. Der G, Everitt BS. Statistical analysis of medical data using SAS. Chapman & Hall/CRC; 2006.
11. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci. 2008;268(1-2):28-32.
12. Martínez HR, Molina-López JF, Cantú-Martínez L, González-Garza MT, Moreno-Cuevas JE, Couret-Alcaraz P, et al. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler. 2011;12(3):199-205.
13. Bettini M, Gargiulo-Monachelli GM, Rodríguez G, Rey RC, Peralta LM, Sica RE. Epidemiology of amyotrophic lateral sclerosis patients in a centre in Buenos Aires. Arq Neuropsiquiatr. 2011;69(6):867-70.
14. Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci. 2008;272(1-2):60-70.
15. Kihira T, Yoshida S, Okamoto K, Kazimoto Y, Ookawa M, Hama K, et al. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci. 2008;268(1-2):95-101.
16. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79(1):33-7.
17. O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79(1):30-2.
18. McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557-70.
19. Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996;47(6 Suppl 4):S233-41.
20. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347(9013):1425-31.
21. Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1-2):194-202.
22. Gordon PH, Corcia P, Lacomblez L, Pochigaeva K, Abitbol JL, Cudkowicz M, et al. Defining survival as an outcome measure in amyotrophic lateral sclerosis. Arch Neurol. 2009;66(6):758-61.
23. Chiò A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G; PARALS. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81(10):1141-3.
24. Tollefsen E, Midgren B, Bakke P, Fondenes O. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. Eur J Neurol. 2010;17(11):1352-7.
25. Ogino M. [End of life care for patients with ALS in Japan]. Rinsho Shinkeigaku. 2008;48(11):973-5.